marginally significantp = 0.013
Applying clinical significance criteria, girls’ prevalence was significantly lower at ages 10–13 compared to ages 14–16 ( ps < 0.005, age 15 marginally significant with p = 0.013; Bonferroni corrected α = 0.003).
Applying clinical significance criteria, girls’ prevalence was significantly lower at ages 10–13 compared to ages 14–16 ( ps < 0.005, age 15 marginally significant with p = 0.013; Bonferroni corrected α = 0.003).